Your browser doesn't support javascript.
loading
Whole genome sequencing reveals the independent clonal origin of multifocal ileal neuroendocrine tumors.
Mäkinen, Netta; Zhou, Meng; Zhang, Zhouwei; Kasai, Yosuke; Perez, Elizabeth; Kim, Grace E; Thirlwell, Chrissie; Nakakura, Eric; Meyerson, Matthew.
Afiliação
  • Mäkinen N; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.
  • Zhou M; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Zhang Z; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.
  • Kasai Y; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Perez E; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.
  • Kim GE; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Thirlwell C; Department of Surgery, University of California, San Francisco, CA, USA.
  • Nakakura E; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.
  • Meyerson M; Department of Pathology, University of California, San Francisco, CA, USA.
Genome Med ; 14(1): 82, 2022 08 03.
Article em En | MEDLINE | ID: mdl-35922826
ABSTRACT

BACKGROUND:

Small intestinal neuroendocrine tumors (SI-NETs) are the most common neoplasms of the small bowel. The majority of tumors are located in the distal ileum with a high incidence of multiple synchronous primary tumors. Even though up to 50% of SI-NET patients are diagnosed with multifocal disease, the mechanisms underlying multiple synchronous lesions remain elusive.

METHODS:

We performed whole genome sequencing of 75 de-identified synchronous primary tumors, 15 metastases, and corresponding normal samples from 13 patients with multifocal ileal NETs to identify recurrent somatic genomic alterations, frequently affected signaling pathways, and shared mutation signatures among multifocal SI-NETs. Additionally, we carried out chromosome mapping of the most recurrent copy-number alterations identified to determine which parental allele had been affected in each tumor and assessed the clonal relationships of the tumors within each patient.

RESULTS:

Absence of shared somatic variation between the synchronous primary tumors within each patient was observed, indicating that these tumors develop independently. Although recurrent copy-number alterations were identified, additional chromosome mapping revealed that tumors from the same patient can gain or lose different parental alleles. In addition to the previously reported CDKN1B loss-of-function mutations, we observed potential loss-of-function gene alterations in TNRC6B, a candidate tumor suppressor gene in a small subset of ileal NETs. Furthermore, we show that multiple metastases in the same patient can originate from either one or several primary tumors.

CONCLUSIONS:

Our study demonstrates major genomic diversity among multifocal ileal NETs, highlighting the need to identify and remove all primary tumors, which have the potential to metastasize, and the need for optimized targeted treatments.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Tumores Neuroendócrinos / Neoplasias Intestinais Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Tumores Neuroendócrinos / Neoplasias Intestinais Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article